Physician profile
Steven Bomeli
NPI 1639372147
$2,256.36
in general payments reported to CMS, 2019-2025
14 companies · $251 in 2025
The $251 reported for 2025 was less than what a typical Otolaryngology provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $81.55 · 2020: $181 · 2022: $147 · 2023: $98.98 · 2024: $1,497 · 2025: $251.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,175 · Travel and Lodging: $672.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,174.80 |
| Travel and Lodging | $672.15 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Aerin Medical INC. | $1,326.28 | 2022-2024 | |
| Genzyme Corporation | $263.52 | 2023-2025 | |
| Medtronic USA, INC. | $150.00 | 2020 | |
| Regeneron Healthcare Solutions, INC. | $128.23 | 2024-2025 | Dupixent |
| Baxter Healthcare | $112.47 | 2022 | |
| Covidien Lp | $81.55 | 2019 | |
| Astrazeneca Pharmaceuticals Lp | $43.40 | 2025 | Tezspire |
| Intersect Ent, INC. | $30.52 | 2020 | |
| Acclarent, INC | $29.28 | 2023 | Trudi Nav Cable |
| Axsome Therapeutics, INC. | $22.88 | 2024 | Sunosi |
| Medtronic, INC. | $22.05 | 2024 | Sinuva |
| Integra Lifesciences Corporation | $16.86 | 2025 | Trudi Probe, Relieva Spinplus Nav, Inspira Air |
| Glaxosmithkline, LLC. | $15.61 | 2024 | Nucala |
| Inspire Medical Systems, INC. | $13.71 | 2025 | Inspire |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steven Bomeli listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.